查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1955469

2026年全球免疫血液学市场报告

Immunohematology Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，免疫血液学市场持续扩张，预计将从2025年的25.6亿美元成长到2026年的26.9亿美元，复合年增长率为4.9%。过去几年的增长可归因于血液疾病盛行率的上升、对安全输血需求的增长、血库的发展、诊断检查室的扩张以及血液学试剂的进步。

预计未来几年免疫血液学市场将维持强劲成长，2030年市场规模将达到32.7亿美元，复合年增长率（CAGR）为5.0%。预测期内的成长要素包括分析仪器的技术创新、人工智慧在实验室诊断中的应用、精准医疗的兴起、数位医疗系统的整合以及血液筛检计画的扩展。预测期内的关键趋势包括先进的血型鑑定技术、免疫血液学检测的自动化、个人化输血疗法、照护现场免疫诊断以及实验室资讯系统的整合。

预计未来几年，社会老化将推动免疫血液学市场的扩张。社会老化指的是老年人口比例不断上升的人口趋势。免疫血液学在满足老龄化的输血需求、确保血液製品的安全使用以及支持老年人的各种医疗程序方面发挥关键作用。例如，根据美国非营利组织人口研究所的估计，截至2024年1月，美国65岁及以上人口预计将从2022年的5,800万增至2050年的8,200万，增幅达47%。同期，该年龄组占总人口的比例预计将从17%增加到23%。因此，人口老化加剧正在推动免疫血液学市场的成长。

免疫血液学市场的主要企业正致力于开发创新诊断解决方案，例如可溶性重组蛋白，旨在克服抗癌药物Daratumumab尤单抗（daratumumab）的干扰。可溶性重组蛋白采用重组DNA技术生产，在可溶性状态下仍能维持正确的摺迭和功能，可有效用于诊断和治疗。例如，西班牙製药公司Grifols于2023年11月推出了Grifols sCD38溶液。本产品是首个专为解决Daratumumab对关键输血相容性检测的干扰而开发的可溶性重组蛋白。此溶液专为多发性骨髓瘤患者设计，可阻断Daratumumab与红血球表面CD38蛋白的结合，实现准确的输血前检测。透过改善筛检、鑑定和交叉配对试验，Grifols sCD38有助于提高输血流程的效率，并减少救命血液製品的供应延误。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球免疫血液学市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 先进的血型鑑定技术
    • 自动化免疫血液学检测
    • 个人化输血疗法
    • 即时免疫诊断
    • 实验室资讯系统集成

第五章 终端用户产业市场分析

  • 血库
  • 诊断与参考检查室
  • 医院
  • 学术研究机构
  • 诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球免疫血液学市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球免疫血液学市场规模、比较及成长率分析
  • 全球免疫血液学市场表现：规模与成长，2020-2025年
  • 全球免疫血液学市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 分析仪器及系统、试剂
  • 透过技术
  • 生物晶片、红血球磁化技术（MET）、凝胶卡、微孔盘、聚合酵素链锁反应（PCR）
  • 因疾病
  • 血液疾病、爱滋病、肝炎
  • 透过使用
  • 输血前检查、免疫溶血检查、周产期检查、血型表型分析、白血球和血小板血清学检查
  • 最终用户
  • 血库、诊断与参考检查室、医院、学术和研究机构
  • 按类型细分：分析仪器和系统
  • 血型鑑定设备、交叉配对试验血设备、凝胶卡系统
  • 按类型细分：试剂
  • 血型鑑定试剂、抗血清、标准血清

第十章 区域与国家分析

  • 全球免疫血液学市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球免疫血液学市场：国家、绩效及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 免疫血液学市场：竞争格局与市场占有率（2024 年）
  • 免疫血液学市场：公司估值矩阵
  • 免疫血液学市场：公司概况
    • Ortho Clinical Diagnostics Inc.
    • Immunocor Inc.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Grifols SA

第37章：其他领先和创新企业

  • Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems SA, Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin SpA

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年免疫血液学市场：提供新机会的国家
  • 2030年免疫血液学市场：充满新机会的细分市场
  • 2030年免疫血液学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: PH5MIMMU04_G26Q1

Immunohematology is a specialized field of laboratory medicine that focuses on the study of blood groups and the immune system's response to foreign substances, particularly in the context of blood transfusions. Immunohematological techniques are applied to identify and resolve diagnostic challenges in patients with blood-related disorders, such as autoimmune hemolytic anemia.

The main products in immunohematology include analyzers, systems, and reagents. Analyzers and systems are automated instruments used for blood typing and antibody screening. The technologies employed include biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, and polymerase chain reaction (PCR), which are used in the diagnosis and management of diseases such as HIV and hepatitis. The key applications include pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, and leukocyte and platelet serology, and these are utilized by end users such as blood banks, diagnostic and reference laboratories, hospitals, and academic and research institutes.

Tariffs have affected the immunohematology market by increasing the cost of imported analyzers, reagents, and lab equipment, leading to higher operational expenses for diagnostic laboratories and hospitals. Segments such as analyzers and reagents are most impacted, particularly in regions like North America and Europe, which rely on imports from Asia-Pacific manufacturing hubs. While tariffs have created cost pressures, they have also encouraged local production and innovation, driving the development of cost-efficient domestic immunohematology solutions.

The immunohematology market research report is one of a series of new reports from The Business Research Company that provides immunohematology market statistics, including immunohematology industry global market size, regional shares, competitors with a immunohematology market share, detailed immunohematology market segments, market trends and opportunities, and any further data you may need to thrive in the immunohematology industry. This immunohematology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohematology market size has grown steadily in recent years. It will grow from $2.56 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to increasing prevalence of blood disorders, rising demand for safe blood transfusions, development of blood banks, growth in diagnostic laboratories, advancements in hematology reagents.

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to technological advancements in analyzers, adoption of AI in laboratory diagnostics, rise in precision medicine, integration of digital health systems, expansion of blood screening programs. Major trends in the forecast period include advanced blood typing techniques, automation in immunohematology testing, personalized transfusion therapy, point-of-care immune diagnostics, integration of laboratory information systems.

The growing aging population is anticipated to drive the expansion of the immunohematology market in the coming years. An aging population describes a demographic trend marked by a rising proportion of elderly individuals within a society. Immunohematology plays a critical role in meeting age-related transfusion requirements, ensuring the safe use of blood products, and supporting a wide range of medical procedures for older adults. For example, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the number of Americans aged 65 years and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. During the same period, this age group's share of the total population is expected to grow from 17% to 23%. Therefore, the expanding aging population is contributing to the growth of the immunohematology market.

Major companies operating in the immunohematology market are focusing on the development of innovative diagnostic solutions, such as soluble recombinant proteins designed to overcome interference caused by the cancer therapy daratumumab. A soluble recombinant protein is produced using recombinant DNA technology and remains properly folded and functional in a soluble form, enabling its effective use in diagnostic and therapeutic applications. For instance, in November 2023, Grifols, S.A., a Spain-based pharmaceutical company, launched the Grifols sCD38 solution. This product is the first soluble recombinant protein developed to address the interference caused by daratumumab during critical blood transfusion compatibility testing. Designed specifically for patients with multiple myeloma, the solution blocks daratumumab from binding to CD38 proteins on red blood cells, enabling accurate pre-transfusion test results. By improving screening, identification, and crossmatching processes, Grifols sCD38 helps streamline transfusion workflows and reduce delays in delivering lifesaving blood products.

In March 2023, Werfen S.A., a Spain-based diagnostic care company, acquired Immucor Inc. for approximately $2 billion. This acquisition was intended to strengthen Werfen's capabilities in specialized diagnostic testing, particularly in transfusion and immunohematology solutions. Immucor Inc. is a transfusion diagnostics company focused on providing safe, accessible, and reliable blood testing technologies.

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunohematology market includes revenues earned by entities by providing blood banking and transfusion medicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohematology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunohematology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohematology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohematology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Analyzers And Systems; Reagents
  • 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (Met); Gel Cards; Microplates; Polymerase Chain Reaction (PCR)
  • 3) By Disease: Blood-Related Diseases; HIV; Hepatitis
  • 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
  • 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
  • Subsegments:
  • 1) By Analyzers And Systems: Blood Typing Analyzers; Cross-Matching Analyzers; Gel Card Systems
  • 2) By Reagents: Blood Grouping Reagents; Antisera; Control Serum
  • Companies Mentioned: Ortho Clinical Diagnostics Inc.; Immunocor Inc.; Abbott Laboratories; Siemens Healthineers AG; Grifols S.A.; Beckman Coulter Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson and Company; Merck Co. & KGaA; Bio-Rad Laboratories; Sysmex Corporation; Danaher Corporation; Biosystems S.A.; Roche Holdings AG; Mindray Medical International Limited; F.Hoffmann La-Roche Ltd.; Biotest AG; Cardinal Health Inc.; Quotient Limited; DiaSorin S.p.A.; Lorne Laboratories Ltd.; Biokit S.A.; Avox Technologies; Diagnostic Automation/Cortez Diagnostics Inc.; Inno-train Diagnostik GmbH; Drucker Diagnostics Inc.; Immundia Diagnostics Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Immunohematology Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Immunohematology Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Immunohematology Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Immunohematology Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Advanced Blood Typing Techniques
    • 4.2.2 Automation In Immunohematology Testing
    • 4.2.3 Personalized Transfusion Therapy
    • 4.2.4 Point-Of-Care Immune Diagnostics
    • 4.2.5 Integration Of Laboratory Information Systems

5. Immunohematology Market Analysis Of End Use Industries

  • 5.1 Blood Banks
  • 5.2 Diagnostic And Reference Laboratories
  • 5.3 Hospitals
  • 5.4 Academic And Research Institutes
  • 5.5 Clinics

6. Immunohematology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunohematology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Immunohematology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Immunohematology Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Immunohematology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Immunohematology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunohematology Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunohematology Market Segmentation

  • 9.1. Global Immunohematology Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Analyzers And Systems, Reagents
  • 9.2. Global Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
  • 9.3. Global Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood-Related Diseases, HIV, Hepatitis
  • 9.4. Global Immunohematology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
  • 9.5. Global Immunohematology Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes
  • 9.6. Global Immunohematology Market, Sub-Segmentation Of Analyzers And Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
  • 9.7. Global Immunohematology Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Grouping Reagents, Antisera, Control Serum

10. Immunohematology Market Regional And Country Analysis

  • 10.1. Global Immunohematology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Immunohematology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunohematology Market

  • 11.1. Asia-Pacific Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunohematology Market

  • 12.1. China Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunohematology Market

  • 13.1. India Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunohematology Market

  • 14.1. Japan Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunohematology Market

  • 15.1. Australia Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunohematology Market

  • 16.1. Indonesia Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunohematology Market

  • 17.1. South Korea Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunohematology Market

  • 18.1. Taiwan Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunohematology Market

  • 19.1. South East Asia Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunohematology Market

  • 20.1. Western Europe Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunohematology Market

  • 21.1. UK Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunohematology Market

  • 22.1. Germany Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunohematology Market

  • 23.1. France Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunohematology Market

  • 24.1. Italy Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunohematology Market

  • 25.1. Spain Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunohematology Market

  • 26.1. Eastern Europe Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunohematology Market

  • 27.1. Russia Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunohematology Market

  • 28.1. North America Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunohematology Market

  • 29.1. USA Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunohematology Market

  • 30.1. Canada Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunohematology Market

  • 31.1. South America Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunohematology Market

  • 32.1. Brazil Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunohematology Market

  • 33.1. Middle East Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunohematology Market

  • 34.1. Africa Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunohematology Market Regulatory and Investment Landscape

36. Immunohematology Market Competitive Landscape And Company Profiles

  • 36.1. Immunohematology Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Immunohematology Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Immunohematology Market Company Profiles
    • 36.3.1. Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Immunohematology Market Other Major And Innovative Companies

  • Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A.

38. Global Immunohematology Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunohematology Market

40. Immunohematology Market High Potential Countries, Segments and Strategies

  • 40.1 Immunohematology Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Immunohematology Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Immunohematology Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer